Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Understanding your monthly semaglutide supply requirements helps you plan your weight loss treatment and manage medication refills effectively. The number of pens needed each month depends on your starting dose, dose progression, and your healthcare provider's treatment protocol. PlexusDx delivers compounded semaglutide injections that adjust to your body's response without changing your monthly price.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Standard Monthly Semaglutide Pen Supply for Weight Loss
Most people beginning semaglutide therapy use one pen per calendar month. This standard supply aligns with the typical dose-escalation protocol, where patients start at 0.25 mg weekly and increase by 0.25 mg increments every four weeks until reaching an effective maintenance dose. Since one standard pen contains four doses of 0.25 mg each, one pen covers the first month of treatment for most new patients.
As your dose increases beyond the starter level, your monthly pen requirements may shift. Patients advancing to 0.5 mg, 0.75 mg, or 1.0 mg weekly doses still typically use one pen per month, because each pen contains a full month's worth of the dose you're prescribed at that stage. Your prescriber tracks your dose progression and coordinates refills so you always have what you need without excess inventory.
The relationship between pen supply and dose level remains consistent by design: manufacturers produce pens to match common monthly dosing schedules. This means your medication arrives aligned with your treatment calendar, reducing confusion about refill timing and supply management.
How Dose Escalation Affects Your Monthly Semaglutide Supply
Semaglutide therapy follows a predictable escalation pattern during the first 16 weeks of treatment. Starting at 0.25 mg weekly, patients increase by 0.25 mg each week for four consecutive weeks, then hold that dose for four weeks before advancing again. This structured approach allows your body to adapt while your provider monitors weight loss progress and side effect tolerance.
Each advancement to a higher weekly dose does not increase the number of pens you receive monthly; instead, PlexusDx adjusts your prescription to match your new dose level. Whether you're taking 0.25 mg, 0.5 mg, 0.75 mg, or 1.0 mg per week, one pen covers four weekly injections at that dose strength. Your monthly price remains steady regardless of which dose tier your treatment reaches, so your dose may need to go up—your price won't.
Maintenance dosing, typically achieved by week 16 to 20 of treatment, settles most patients at 1.0 mg to 2.4 mg weekly. At these doses, some patients may transition to higher-concentration formulations or multi-month supplies, but standard single-monthly pens remain the most common distribution model for consistent, predictable therapy.
Comparing Brand Ozempic Pens to Compounded Semaglutide Supply
Brand-name Ozempic pens and compounded semaglutide from licensed 503A pharmacies follow similar supply patterns for monthly treatment. Both typically ship one pen per month aligned with your current dose, and both require coordination between your provider and pharmacy for dose adjustments. The key difference lies in cost, accessibility, and personalization options rather than how many pens you'll receive.
PlexusDx compounded semaglutide injections eliminate insurance requirements, offer HSA/FSA eligibility, and serve all 50 states with consistent monthly pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan. Because PlexusDx uses licensed 503A compounding pharmacies—not 503B manufacturers—your medication is prepared under pharmacist oversight with formulation flexibility that brand pens cannot match. Your monthly supply adjusts to your dose without the insurance denials, prior authorizations, or price surprises that often accompany branded options.
Both approaches deliver one pen per month for standard escalation and maintenance phases. The difference appears in your out-of-pocket cost, approval timeline, and whether your specific dosing needs require custom compounding that a fixed brand formulation cannot provide.
Planning Your Semaglutide Refills and Supply Timeline
Effective medication management begins with setting a reliable refill schedule aligned with your injection day. If you inject on the same day each week—a common practice for consistency—you'll use the four doses in your monthly pen across exactly four weeks. Ordering your next pen seven to ten days before your current supply runs out ensures no lapse in your treatment and prevents missed doses during the escalation phase when consistency matters most.
PlexusDx coordinates refills automatically once you're established on your maintenance dose, removing the need to call your pharmacy each month. You'll receive one pen per month on a predictable schedule, allowing you to stock your medication properly and plan your injections without last-minute rushes. If your dose changes during escalation, your provider updates your prescription, and PlexusDx adjusts your next shipment to match.
Keep track of your injection dates in a calendar or phone app to stay ahead of refill timing. If you're traveling or anticipating a schedule disruption, notify PlexusDx at least two weeks in advance so your pen arrives when you need it. This proactive approach prevents gaps in your treatment and maintains the consistent weekly dosing that maximizes your weight loss results.
Personalized Dosing and the Precision Peptide Genetic Test
The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Patients with certain genetic profiles may reach optimal weight loss at lower maintenance doses, while others benefit from advancing to higher doses for better appetite suppression. The Precision Peptide test maps 14 pathways, 49 peptides, and 150+ genetic insights, giving your prescriber data-driven guidance for your specific treatment plan. This personalization may affect when you stabilize on your maintenance dose, but your monthly pen supply remains one per month at your prescribed dose level—ensuring predictable costs and consistent access throughout your journey.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.
Frequently Asked Questions
How many Ozempic pens do I need for one month of treatment?
Most patients require one pen per month during both the dose-escalation and maintenance phases of semaglutide therapy. One pen contains four 0.25 mg doses, which aligns with the standard four-week treatment cycle. Your prescriber adjusts your dose level, not the number of pens, as you progress through your treatment plan.
Does my pen supply change when my dose increases?
No. You continue receiving one pen per month regardless of your dose level. When your dose increases from 0.25 mg to 0.5 mg weekly, your pen changes formulation, but the monthly quantity stays the same. PlexusDx ensures your dose may need to go up—your price won't, keeping your monthly cost flat at $189/mo for compounded semaglutide injection.
What is the difference between brand-name Ozempic and PlexusDx compounded semaglutide?
Both deliver one pen per month, but PlexusDx compounded semaglutide comes from licensed 503A pharmacies, requires no insurance, costs are $189/mo month-to-month, or from $149/mo on the 6-month plan, and is HSA/FSA eligible across all 50 states. Brand Ozempic often involves insurance barriers, prior authorizations, and higher out-of-pocket costs. The monthly supply pattern is the same, but PlexusDx offers greater accessibility and predictable pricing.
Can I get a multi-month supply of semaglutide pens?
Standard protocol delivers one pen monthly to match your current dose and treatment phase. Multi-month supplies are less common for semaglutide because your dose typically increases during the first 16 weeks of treatment. Once you stabilize on a maintenance dose, your PlexusDx provider may discuss alternative supply options—contact your care team to explore what works best for your situation.
How does the Precision Peptide Genetic Test affect my semaglutide supply?
The Precision Peptide Genetic Test identifies your genetic predispositions for GLP-1 receptor sensitivity and appetite control, helping your PlexusDx provider personalize your dose escalation and maintenance target. Test results may accelerate or adjust your dose progression timeline, but your monthly pen supply remains one per month at your prescribed dose. The $298 test is available as an add-on after your first month of treatment and provides 150+ genetic insights to optimize your therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Stop Taking Ozempic Safely for Weight Loss
Does the Wegovy Pen Hurt? A Guide to a Painless Weight Loss Journey